475 related articles for article (PubMed ID: 21049267)
1. Tolerance and cross-tolerance to neurocognitive effects of THC and alcohol in heavy cannabis users.
Ramaekers JG; Theunissen EL; de Brouwer M; Toennes SW; Moeller MR; Kauert G
Psychopharmacology (Berl); 2011 Mar; 214(2):391-401. PubMed ID: 21049267
[TBL] [Abstract][Full Text] [Related]
2. Neurocognitive performance during acute THC intoxication in heavy and occasional cannabis users.
Ramaekers JG; Kauert G; Theunissen EL; Toennes SW; Moeller MR
J Psychopharmacol; 2009 May; 23(3):266-77. PubMed ID: 18719045
[TBL] [Abstract][Full Text] [Related]
3. Single doses of THC and cocaine decrease proficiency of impulse control in heavy cannabis users.
van Wel JH; Kuypers KP; Theunissen EL; Toennes SW; Spronk DB; Verkes RJ; Ramaekers JG
Br J Pharmacol; 2013 Dec; 170(7):1410-20. PubMed ID: 24106872
[TBL] [Abstract][Full Text] [Related]
4. Neurophysiological functioning of occasional and heavy cannabis users during THC intoxication.
Theunissen EL; Kauert GF; Toennes SW; Moeller MR; Sambeth A; Blanchard MM; Ramaekers JG
Psychopharmacology (Berl); 2012 Mar; 220(2):341-50. PubMed ID: 21975580
[TBL] [Abstract][Full Text] [Related]
5. Acute and residual mood and cognitive performance of young adults following smoked cannabis.
Matheson J; Mann RE; Sproule B; Huestis MA; Wickens CM; Stoduto G; George TP; Rehm J; Le Foll B; Brands B
Pharmacol Biochem Behav; 2020 Jul; 194():172937. PubMed ID: 32360692
[TBL] [Abstract][Full Text] [Related]
6. Cannabidiol (CBD) content in vaporized cannabis does not prevent tetrahydrocannabinol (THC)-induced impairment of driving and cognition.
Arkell TR; Lintzeris N; Kevin RC; Ramaekers JG; Vandrey R; Irwin C; Haber PS; McGregor IS
Psychopharmacology (Berl); 2019 Sep; 236(9):2713-2724. PubMed ID: 31044290
[TBL] [Abstract][Full Text] [Related]
7. Cognitive and psychomotor effects in males after smoking a combination of tobacco and cannabis containing up to 69 mg delta-9-tetrahydrocannabinol (THC).
Hunault CC; Mensinga TT; Böcker KB; Schipper CM; Kruidenier M; Leenders ME; de Vries I; Meulenbelt J
Psychopharmacology (Berl); 2009 May; 204(1):85-94. PubMed ID: 19099294
[TBL] [Abstract][Full Text] [Related]
8. A placebo-controlled study to assess Standardized Field Sobriety Tests performance during alcohol and cannabis intoxication in heavy cannabis users and accuracy of point of collection testing devices for detecting THC in oral fluid.
Bosker WM; Theunissen EL; Conen S; Kuypers KP; Jeffery WK; Walls HC; Kauert GF; Toennes SW; Moeller MR; Ramaekers JG
Psychopharmacology (Berl); 2012 Oct; 223(4):439-46. PubMed ID: 22581391
[TBL] [Abstract][Full Text] [Related]
9. Cognition and motor control as a function of Delta9-THC concentration in serum and oral fluid: limits of impairment.
Ramaekers JG; Moeller MR; van Ruitenbeek P; Theunissen EL; Schneider E; Kauert G
Drug Alcohol Depend; 2006 Nov; 85(2):114-22. PubMed ID: 16723194
[TBL] [Abstract][Full Text] [Related]
10. The safety of modafinil in combination with oral ∆9-tetrahydrocannabinol in humans.
Sugarman DE; Poling J; Sofuoglu M
Pharmacol Biochem Behav; 2011 Mar; 98(1):94-100. PubMed ID: 21176784
[TBL] [Abstract][Full Text] [Related]
11. Modulation of acute effects of delta-9-tetrahydrocannabinol on psychotomimetic effects, cognition and brain function by previous cannabis exposure.
Colizzi M; McGuire P; Giampietro V; Williams S; Brammer M; Bhattacharyya S
Eur Neuropsychopharmacol; 2018 Jul; 28(7):850-862. PubMed ID: 29935939
[TBL] [Abstract][Full Text] [Related]
12. Cannabis and tolerance: acute drug impairment as a function of cannabis use history.
Ramaekers JG; van Wel JH; Spronk DB; Toennes SW; Kuypers KP; Theunissen EL; Verkes RJ
Sci Rep; 2016 May; 6():26843. PubMed ID: 27225696
[TBL] [Abstract][Full Text] [Related]
13. Medicinal Δ(9) -tetrahydrocannabinol (dronabinol) impairs on-the-road driving performance of occasional and heavy cannabis users but is not detected in Standard Field Sobriety Tests.
Bosker WM; Kuypers KP; Theunissen EL; Surinx A; Blankespoor RJ; Skopp G; Jeffery WK; Walls HC; van Leeuwen CJ; Ramaekers JG
Addiction; 2012 Oct; 107(10):1837-44. PubMed ID: 22553980
[TBL] [Abstract][Full Text] [Related]
14. High-potency marijuana impairs executive function and inhibitory motor control.
Ramaekers JG; Kauert G; van Ruitenbeek P; Theunissen EL; Schneider E; Moeller MR
Neuropsychopharmacology; 2006 Oct; 31(10):2296-303. PubMed ID: 16572123
[TBL] [Abstract][Full Text] [Related]
15. Evaluation of divided attention psychophysical task performance and effects on pupil sizes following smoked, vaporized and oral cannabis administration.
Newmeyer MN; Swortwood MJ; Taylor ME; Abulseoud OA; Woodward TH; Huestis MA
J Appl Toxicol; 2017 Aug; 37(8):922-932. PubMed ID: 28138971
[TBL] [Abstract][Full Text] [Related]
16. Cannabis and cocaine decrease cognitive impulse control and functional corticostriatal connectivity in drug users with low activity DBH genotypes.
Ramaekers JG; van Wel JH; Spronk D; Franke B; Kenis G; Toennes SW; Kuypers KP; Theunissen EL; Stiers P; Verkes RJ
Brain Imaging Behav; 2016 Dec; 10(4):1254-1263. PubMed ID: 26667034
[TBL] [Abstract][Full Text] [Related]
17. Cannabis with high δ9-THC contents affects perception and visual selective attention acutely: an event-related potential study.
Böcker KB; Gerritsen J; Hunault CC; Kruidenier M; Mensinga TT; Kenemans JL
Pharmacol Biochem Behav; 2010 Jul; 96(1):67-74. PubMed ID: 20417659
[TBL] [Abstract][Full Text] [Related]
18. Controlled vaporized cannabis, with and without alcohol: subjective effects and oral fluid-blood cannabinoid relationships.
Hartman RL; Brown TL; Milavetz G; Spurgin A; Gorelick DA; Gaffney G; Huestis MA
Drug Test Anal; 2016 Jul; 8(7):690-701. PubMed ID: 26257143
[TBL] [Abstract][Full Text] [Related]
19. The effect of high-dose dronabinol (oral THC) maintenance on cannabis self-administration.
Schlienz NJ; Lee DC; Stitzer ML; Vandrey R
Drug Alcohol Depend; 2018 Jun; 187():254-260. PubMed ID: 29689485
[TBL] [Abstract][Full Text] [Related]
20. Acute Pharmacokinetic Profile of Smoked and Vaporized Cannabis in Human Blood and Oral Fluid.
Spindle TR; Cone EJ; Schlienz NJ; Mitchell JM; Bigelow GE; Flegel R; Hayes E; Vandrey R
J Anal Toxicol; 2019 May; 43(4):233-258. PubMed ID: 30615181
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
